Taiko Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4574.T

Taiko Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending December 31, 2022: USD 0.88

Taiko Pharmaceutical Co.,Ltd. Revenue Per Share is USD 0.88 for the year ending December 31, 2022, a -58.82% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Taiko Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 2.14, a -45.99% change year over year.
  • Taiko Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 3.96, a 21.58% change year over year.
  • Taiko Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending March 31, 2020 was USD 3.26, a 49.36% change year over year.
  • Taiko Pharmaceutical Co.,Ltd. Revenue Per Share for the year ending March 31, 2019 was USD 2.18, a 4.30% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
Tokyo Stock Exchange: 4574.T

Taiko Pharmaceutical Co.,Ltd.

CEO Mr. Takashi Shibata
IPO Date March 18, 2009
Location Japan
Headquarters 1-4-1, Nishi-Honmachi
Employees 208
Sector Health Care
Industries
Description

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`

Similar companies

4554.T

Fuji Pharma Co., Ltd.

USD 9.68

0.67%

4506.T

Sumitomo Pharma Co., Ltd.

USD 3.49

1.85%

4551.T

Torii Pharmaceutical Co., Ltd.

USD 29.58

-1.24%

4569.T

KYORIN Holdings, Inc.

USD 9.17

-0.53%

StockViz Staff

January 15, 2025

Any question? Send us an email